Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Available

An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG

This is an open-label, expanded access trial designed to provide access to cretostimogene in patients with NMIBC (specifically CIS with or without HG Ta/T1) unresponsive to BCG.

Trial details
Age: 18+Biological sex: AllType: Expanded AccessSponsor: CG Oncology, Inc.Updated: Apr 14, 2026Locations: 26
Eligibility criteria

Pathologically confirmed relapsed or persistent CIS (with or without HG Ta or HG... [+4]

Muscle invasive bladder cancer, locally advanced or metastatic bladder cancer. [+3]

Read more
Status: Recruiting

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

This is a Phase 2, Multi-Arm, Multi-Cohort, Open-Label Study to Evaluate the Safety and Efficacy of Cretostimogene Grenadenorepvec in Participants with High-Risk Non-Muscle-Invasive Bladder Cancer.

Participants needed: 325
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: CG Oncology, Inc.Updated: Apr 8, 2026Locations: 65
Eligibility criteria

Pathologically confirmed BCG-naïve high-risk high-grade NMIBC (i.e., CIS with or... [+8]

Current or past history of muscle-invasive, locally advanced or metastatic bladd... [+4]

Read more